Up-Regulation of p53/miR-628-3p Pathway, a Novel Mechanism of Shikonin on Inhibiting Proliferation and Inducing Apoptosis of A549 and PC-9 Non–Small Cell Lung Cancer Cell Lines

Shikonin (SHK) is a pleiotropic agent with remarkable cell growth inhibition activity against various cancer types, especially non–small cell lung cancer (NSCLC), but its molecular mechanism is still unclear. Our previous study found that miR-628-3p could inhibit the growth of A549 cells and induce...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jieli Pan, Meiya Li, Fenglin Yu, Feiye Zhu, Linyan Wang, Dandan Ning, Xiaoli Hou, Fusheng Jiang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
p53
Acceso en línea:https://doaj.org/article/37f8f2e0ccb14e8dafed70c71211a9dc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:37f8f2e0ccb14e8dafed70c71211a9dc
record_format dspace
spelling oai:doaj.org-article:37f8f2e0ccb14e8dafed70c71211a9dc2021-11-16T04:55:41ZUp-Regulation of p53/miR-628-3p Pathway, a Novel Mechanism of Shikonin on Inhibiting Proliferation and Inducing Apoptosis of A549 and PC-9 Non–Small Cell Lung Cancer Cell Lines1663-981210.3389/fphar.2021.766165https://doaj.org/article/37f8f2e0ccb14e8dafed70c71211a9dc2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.766165/fullhttps://doaj.org/toc/1663-9812Shikonin (SHK) is a pleiotropic agent with remarkable cell growth inhibition activity against various cancer types, especially non–small cell lung cancer (NSCLC), but its molecular mechanism is still unclear. Our previous study found that miR-628-3p could inhibit the growth of A549 cells and induce its apoptosis. Bioinformatics analysis predicted that miR-628-3p promoter sequence contained p53 binding sites. Considering the regulatory effect of SHK on p53, we speculate that SHK may inhibit the growth and induce apoptosis of NSCLC cells by up-regulating miR-628-3p. CCK-8 and EdU assay confirmed the inhibitory effect of SHK on A549 and PC-9 cells. Meanwhile, quantitative reverse transcription–polymerase chain reaction and Western blot showed that SHK could promote the expression of p53 and miR-628-3p in a dose-dependent manner. Overexpression of p53 or miR-628-3p can inhibit the growth and promote apoptosis of A549 and PC-9 cells, while silencing p53 or miR-628-3p has the opposite effect. Dual luciferase reporting assay and ChIP (chromatin immunoprecipitation) assay further verified the direct interaction between p53 and the promoter of miR-628-3p. Gene knockdown for p53 or miR-628-3p confirmed that SHK inhibits the growth and induces apoptosis of A549 and PC-9 cells at least partly by up-regulating p53/miR-628-3p signaling pathway. Therefore, these novel findings provide an alternative approach to target p53/miR-628-3p axis and could be used for the development of new treatment strategies for NSCLC.Jieli PanMeiya LiFenglin YuFeiye ZhuLinyan WangDandan NingXiaoli HouFusheng JiangFrontiers Media S.A.articleshikoninnon–small cell lung cancerp53miRNAproliferationapoptosisTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic shikonin
non–small cell lung cancer
p53
miRNA
proliferation
apoptosis
Therapeutics. Pharmacology
RM1-950
spellingShingle shikonin
non–small cell lung cancer
p53
miRNA
proliferation
apoptosis
Therapeutics. Pharmacology
RM1-950
Jieli Pan
Meiya Li
Fenglin Yu
Feiye Zhu
Linyan Wang
Dandan Ning
Xiaoli Hou
Fusheng Jiang
Up-Regulation of p53/miR-628-3p Pathway, a Novel Mechanism of Shikonin on Inhibiting Proliferation and Inducing Apoptosis of A549 and PC-9 Non–Small Cell Lung Cancer Cell Lines
description Shikonin (SHK) is a pleiotropic agent with remarkable cell growth inhibition activity against various cancer types, especially non–small cell lung cancer (NSCLC), but its molecular mechanism is still unclear. Our previous study found that miR-628-3p could inhibit the growth of A549 cells and induce its apoptosis. Bioinformatics analysis predicted that miR-628-3p promoter sequence contained p53 binding sites. Considering the regulatory effect of SHK on p53, we speculate that SHK may inhibit the growth and induce apoptosis of NSCLC cells by up-regulating miR-628-3p. CCK-8 and EdU assay confirmed the inhibitory effect of SHK on A549 and PC-9 cells. Meanwhile, quantitative reverse transcription–polymerase chain reaction and Western blot showed that SHK could promote the expression of p53 and miR-628-3p in a dose-dependent manner. Overexpression of p53 or miR-628-3p can inhibit the growth and promote apoptosis of A549 and PC-9 cells, while silencing p53 or miR-628-3p has the opposite effect. Dual luciferase reporting assay and ChIP (chromatin immunoprecipitation) assay further verified the direct interaction between p53 and the promoter of miR-628-3p. Gene knockdown for p53 or miR-628-3p confirmed that SHK inhibits the growth and induces apoptosis of A549 and PC-9 cells at least partly by up-regulating p53/miR-628-3p signaling pathway. Therefore, these novel findings provide an alternative approach to target p53/miR-628-3p axis and could be used for the development of new treatment strategies for NSCLC.
format article
author Jieli Pan
Meiya Li
Fenglin Yu
Feiye Zhu
Linyan Wang
Dandan Ning
Xiaoli Hou
Fusheng Jiang
author_facet Jieli Pan
Meiya Li
Fenglin Yu
Feiye Zhu
Linyan Wang
Dandan Ning
Xiaoli Hou
Fusheng Jiang
author_sort Jieli Pan
title Up-Regulation of p53/miR-628-3p Pathway, a Novel Mechanism of Shikonin on Inhibiting Proliferation and Inducing Apoptosis of A549 and PC-9 Non–Small Cell Lung Cancer Cell Lines
title_short Up-Regulation of p53/miR-628-3p Pathway, a Novel Mechanism of Shikonin on Inhibiting Proliferation and Inducing Apoptosis of A549 and PC-9 Non–Small Cell Lung Cancer Cell Lines
title_full Up-Regulation of p53/miR-628-3p Pathway, a Novel Mechanism of Shikonin on Inhibiting Proliferation and Inducing Apoptosis of A549 and PC-9 Non–Small Cell Lung Cancer Cell Lines
title_fullStr Up-Regulation of p53/miR-628-3p Pathway, a Novel Mechanism of Shikonin on Inhibiting Proliferation and Inducing Apoptosis of A549 and PC-9 Non–Small Cell Lung Cancer Cell Lines
title_full_unstemmed Up-Regulation of p53/miR-628-3p Pathway, a Novel Mechanism of Shikonin on Inhibiting Proliferation and Inducing Apoptosis of A549 and PC-9 Non–Small Cell Lung Cancer Cell Lines
title_sort up-regulation of p53/mir-628-3p pathway, a novel mechanism of shikonin on inhibiting proliferation and inducing apoptosis of a549 and pc-9 non–small cell lung cancer cell lines
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/37f8f2e0ccb14e8dafed70c71211a9dc
work_keys_str_mv AT jielipan upregulationofp53mir6283ppathwayanovelmechanismofshikoninoninhibitingproliferationandinducingapoptosisofa549andpc9nonsmallcelllungcancercelllines
AT meiyali upregulationofp53mir6283ppathwayanovelmechanismofshikoninoninhibitingproliferationandinducingapoptosisofa549andpc9nonsmallcelllungcancercelllines
AT fenglinyu upregulationofp53mir6283ppathwayanovelmechanismofshikoninoninhibitingproliferationandinducingapoptosisofa549andpc9nonsmallcelllungcancercelllines
AT feiyezhu upregulationofp53mir6283ppathwayanovelmechanismofshikoninoninhibitingproliferationandinducingapoptosisofa549andpc9nonsmallcelllungcancercelllines
AT linyanwang upregulationofp53mir6283ppathwayanovelmechanismofshikoninoninhibitingproliferationandinducingapoptosisofa549andpc9nonsmallcelllungcancercelllines
AT dandanning upregulationofp53mir6283ppathwayanovelmechanismofshikoninoninhibitingproliferationandinducingapoptosisofa549andpc9nonsmallcelllungcancercelllines
AT xiaolihou upregulationofp53mir6283ppathwayanovelmechanismofshikoninoninhibitingproliferationandinducingapoptosisofa549andpc9nonsmallcelllungcancercelllines
AT fushengjiang upregulationofp53mir6283ppathwayanovelmechanismofshikoninoninhibitingproliferationandinducingapoptosisofa549andpc9nonsmallcelllungcancercelllines
_version_ 1718426717093101568